The FDA gave tentative approval to Dr. Reddy’s Laboratories to make a generic version of a groundbreaking HIV prevention ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

A person in Washington state has died from complications of the bird flu, the first such U.S. death in a year.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Five Bay Area labs teamed up to compare lasting effects of psilocybin on anxiety and depression-like behavior in mice, with limited results: ...

MRT is not legal in the U.S. But medical tourism agencies charge thousands of dollars to connect women to clinics around the ...

Health care affordability is a major issue for voters, and a new kind of medical clinic sticks some patients with big bills.

Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government ...

No matter what happens on Election Day, the midterms will have sweeping implications for American health care. More than two ...

Officials are moving behind the scenes to head off a conflict brewing between states and the federal government over ...

The task force is a critical advisory body to HHS, reviewing scientific evidence to provide recommendations on whether ...